"At RPG, our endeavour is to build resilient businesses with sustainable growth aimed at creating value for our stakeholders."
Pramod Menon
Group CFO, RPG Enterprise
CEAT
ANNUAL REPORT (FY23)
₹ 11,224 Cr
Market Cap
QUARTERLY RESULTS (Q4 FY24)
Statement of Consolidated Financial Results on 2nd May 2024
LATEST FINANCIAL PRESS RELEASE (Q4 FY24)
CEAT delivers Consolidated Revenue of Rs. 2,991.9 crore in Q4 FY24; Growth of 1.0% Q-o-Q; 4.1% Y-o-Y
EARNINGS CALL TRANSCRIPT (Q4 FY24)
CEAT Limited Q4 FY24 Earnings Call - May 03, 2024
KEC International
ANNUAL REPORT (FY23)
₹ 24,612 Cr
Market Cap
QUARTERLY RESULTS (Q4 FY24)
Statement of Consolidated Financial Results on 7th May, 2024
LATEST FINANCIAL PRESS RELEASE (Q4 FY24)
KEC delivers all time high Revenues - Grows by 12% in Q4 and 15% in FY24 PBT and PAT grows by two times in Q4 and FY24
EARNINGS CALL TRANSCRIPT (Q4 FY24)
"KEC International Limited Q4 FY '24 Results Conference Call" May 08, 2024
Zensar
ANNUAL REPORT (FY23)
₹ 15,862 Cr
Market Cap
QUARTERLY RESULTS (Q4 FY24)
Statement of Consolidated Financial Results on March, 2024
LATEST FINANCIAL PRESS RELEASE (Q4 FY24)
Zensar reports 2.4% QoQ revenue growth and PAT growth of 7.6% for Q4FY24
EARNINGS CALL TRANSCRIPT (Q4 FY24)
Zensar Technologies Limited Q4 FY24 Earnings Call, April 25, 2024
RPG Life Sciences
ANNUAL REPORT (FY23)
₹ 3,945 Cr
Market Cap
QUARTERLY RESULTS (Q4 FY24)
Statement of Consolidated Financial Results on 31st March, 2024
LATEST FINANCIAL PRESS RELEASE (Q4 FY24)
RPG Life Sciences Achieves Remarkable Growth in FY24: 14% Revenue Increase and 29% PBT Growth Year-on-Year, EBITDA Margin Expands to 23.3%
EARNINGS CALL TRANSCRIPT (Q4 FY24)
RPG Life Sciences Limited Q4 FY '24 Earnings Call, May 02, 2024
Harrisons Malayalam
ANNUAL REPORT 2021 - 2022
₹ 481 Cr
Market Cap
